Icagen, Inc. announced it will release financial results for the fourth quarter and full year 2009 on Tuesday, March 30, 2010. Icagen Inc. trades on the “NASDAQ” under the stock symbol “ICGN”. For the Latest information regarding “ICGN”, make sure to visit the Most Exclusive and In Depth newsletter website at: http://www.wallstreetgrand.com/.
Icagen, Inc. (NASDAQ:ICGN) today announced it will release financial results for the fourth quarter and full year 2009 on Tuesday, March 30, 2010. The Company will also conduct a conference call that day at 10:00 a.m. Eastern Time to discuss results and highlights of the fourth quarter and full year 2009.
|
Conference call details: |
|
|
Date: |
Tuesday, March 30, 2010 |
|
Time: |
10:00 a.m. ET |
|
Dial-in (U.S. and Canada): |
800-659-2032 |
|
Dial-in (International): |
617-614-2712 |
|
Access code: |
31373231 |
|
Web cast: |
http://www.icagen.com |
An archived version of the webcast will also be available on Icagen's website for at least two weeks following the call. A playback of the call will be available from approximately 12:00 p.m. Eastern Time on March 30, 2010 for seven days and may be accessed by dialing:
|
Access number (U.S. and Canada): |
888-286-8010 |
|
Access number (International): |
617-801-6888 |
|
Access code: |
65508899 |
About Icagen Inc:
Icagen, Inc. is a biopharmaceutical company based in Research Triangle Park, North Carolina, focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. Utilizing its proprietary know-how and integrated scientific and drug development capabilities, Icagen has identified multiple drug candidates that modulate ion channels. The Company is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. The Company has a clinical stage program in epilepsy and pain.
You can contact us during market hours at 1-888-9-ClubGrand (1888-925-8247) or via email at staff@wallstreetgrand.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") including 2009 growth, revenue for the second quarter and year of 2009 and gross margin for the second quarter and year of 2009. Additionally, words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the impact of intense competition, the continuation or worsening of current economic conditions and the condition of the domestic and global credit and capital markets.
Disclaimer:
Wall Street Grand LLC has not been compensated by the company for this press release and does not expect to be compensated in the future for any type of awareness. To read our full disclaimer clicks the link http://www.wallstreetgrand.com/disclosure.html.
